VA106483 Dose Response in Females

Completed · Phase 1 · Has a placebo group

Conditions studied: Nocturia

In brief

The purpose of this study is to describe the pharmacokinetics and pharmacodynamics of VA106483 in female subjects.

Key facts

Study ID
NCT01171391
Run by
Vantia Ltd
People needed
21
Starts
2010-07-01
Expected to finish
2010-11-01
Last updated by the study team
2010-12-01

Who can join

Age: 40 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.